Copyright
©2013 Baishideng Publishing Group Co.
World J Cardiol. Jan 26, 2013; 5(1): 1-7
Published online Jan 26, 2013. doi: 10.4330/wjc.v5.i1.1
Published online Jan 26, 2013. doi: 10.4330/wjc.v5.i1.1
Table 1 Patients’ characteristics (mean ± SD) n (%)
| NonVSA group | VSA group | P value | |
| (n = 36) | (n = 36) | ||
| Age (yr) | 60 ± 9 | 59 ± 9 | NS |
| Male/female | 31/5 | 30/6 | NS |
| Body mass index (kg/m2) | 25.2 ± 3.2 | 23.2 ± 2.6 | 0.0045 |
| Coronary risk facto | |||
| Smoking | 25 (69) | 24 (67) | NS |
| Current/passt smoker | 11/13 | 12/13 | NS |
| Hypertension | 21 (58) | 19 (53) | NS |
| Dyslipidemia | 11 (31) | 11 (31) | NS |
| Diabetes mellitus | 9 (25) | 4 (11) | NS |
| Taking statins (%) | 4 (11) | 3 (9) | NS |
| LVEF on echocardiography (%) | 71 ± 8 | 68 ± 7 | NS |
Table 2 Blood chemical parameters (mean ± SD)
| NonVSA Group | VSA Group | P value | |
| Total cholesterol (mg/dL) | 196 ± 38 | 205 ± 27 | NS |
| Triglyceride (mg/dL) | 158 ± 63 | 142 ± 57 | NS |
| HDL-cholesterol (mg/dL) | 52 ± 15 | 55 ± 13 | NS |
| LDL-cholesterol (mg/dL) | 113 ± 30 | 123 ± 24 | NS |
| Fasting blood sugar (mg/dL) | 103 ± 24 | 97 ± 13 | NS |
| Hemoglobin A1C (%) | 5.6 ± 0.8 | 5.4 ± 0.6 | NS |
| C-reactive protein (mg/L) | 1.8 ± 2.9 | 1.6 ± 3.6 | NS |
Table 3 Quantitative coronary angiography and Doppler flow velocity (mean ± SD)
| NonVSA Group | VSA Group | P value | |
| Heart rate at baseline (/min) | 67 ± 13 | 67 ± 9 | NS |
| Mean arterial pressure (mmHg) | 107 ± 11 | 103 ± 16 | NS |
| Coronary artery diameter (mm) | |||
| Baseline | 3.14 ± 0.48 | 2.95 ± 0.55 | NS |
| Acetylcholine 3 μg/min | 3.24 ± 0.55 | 2.90 ± 0.59 | 0.013 |
| Nitroglycerin infusion | 3.57 ± 0.65 | 3.43 ± 0.55 | NS |
| Coronary blood flow (mL/min) | |||
| Baseline | 94 ± 48 | 84 ± 69 | NS |
| Acetylcholine 3 μg/min | 153 ± 15 | 130 ± 15 | NS |
| Average peak velocity (cm/s) | |||
| Baseline | 21 ± 8 | 21 ± 12 | NS |
| After ATP infusion | 63 ± 25 | 64 ± 24 | NS |
Table 4 Relationship between clinical parameters and coronary microvascular function (mean ± SD)
| Parameters | ACh-induced increase in CBF | P value | CFR | P value |
| Age (yr) | r = 0.188 | NS | r = 0.204 | NS |
| Disease period (mo) | r = -0.016 | NS | r = -0.260 | NS |
| Current smoking | ||||
| (+, n = 12) | 54.5 ± 14.0 | NS | 3.1 ± 0.6 | NS |
| (-, n = 24) | 54.4 ± 9.9 | 3.3 ± 0.8 | ||
| Diffuse spasm | ||||
| (+, n = 23) | 60.8 ± 49.9 | NS | 3.2 ± 0.6 | NS |
| (-, n = 13) | 43.2 ± 43.3 | 3.3 ± 0.9 | ||
| Distal spasm | ||||
| (+, n = 20) | 57.0 ± 49.3 | NS | 3.2 ± 0.7 | NS |
| (-, n = 16) | 51.3 ± 47.2 | 3.3 ± 0.8 | ||
| Multi-vessel spasm | ||||
| (+, n = 7) | 41.8 ± 26.4 | NS | 3.1 ± 0.7 | NS |
| (-, n = 29) | 57.5 ± 51.5 | 3.3 ± 0.7 |
- Citation: Teragawa H, Mitsuba N, Ishibashi K, Nishioka K, Kurisu S, Kihara Y. Evaluation of coronary microvascular function in patients with vasospastic angina. World J Cardiol 2013; 5(1): 1-7
- URL: https://www.wjgnet.com/1949-8462/full/v5/i1/1.htm
- DOI: https://dx.doi.org/10.4330/wjc.v5.i1.1
